Clinical Trial Update: A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated whether using alcohol wipes before daily Copaxone injections reduces injection-site skin reactions in people with multiple sclerosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Teva Neuroscience, Inc. | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED